Voriconazole-induced severe skin allergy and neurological adverse event in a liver failure patient: A case report

J Clin Pharm Ther. 2022 Oct;47(10):1725-1728. doi: 10.1111/jcpt.13774. Epub 2022 Sep 12.

Abstract

What is known and objective: Triazole antifungal-associated severe skin allergy has received little attention. Here we report a case of an acute-on-chronic liver failure (ACLF) patient with diffused skin allergy pervading from the chest, abdomen, back, knees to perineum, with red colour and partially desquamation as well as a neurological adverse (insomnia) event after voriconazole treatment.

Case summary: A 40-year-old man with liver failure in our hospital had received voriconazole for invasive fungal infection therapy, and while waiting for liver transplantation exhibited a severe diffuse rash and a neurological adverse event.

What is new and conclusion: To the best of our knowledge, this is the first report of a liver failure patient who suffered a severe allergy accompanied with a neurological adverse event after voriconazole administration.

Keywords: antifungals; insomnia; liver failure; severe skin allergy; voriconazole.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antifungal Agents
  • Humans
  • Hypersensitivity* / drug therapy
  • Liver Failure* / chemically induced
  • Liver Failure* / drug therapy
  • Male
  • Triazoles
  • Voriconazole / adverse effects

Substances

  • Antifungal Agents
  • Triazoles
  • Voriconazole